Literature DB >> 15517310

Human cerebral infarct: a proposed histopathologic classification based on 137 cases.

Hernando Mena1, Diego Cadavid, Elisabeth J Rushing.   

Abstract

We studied the microscopic features of 137 cases of human cerebral infarct. In each case, the age of the lesion was determined by measuring the time elapsed between initial clinical presentation and date of surgery or death. Multiple microscopic variables were analyzed on hematoxylin and eosin-stained sections. There were 104 (76%) male and 33 (24%) female patients with a median age of 64 years. The location of the infarcts included 129 cerebral, 5 cerebellar, and 1 each in the pons, midbrain and medulla. The age of the lesions ranged from 1 day to 53 years. All lesions were single and varied from lacunes to large infarcts in the distribution of one or more cerebral arteries. Key histologic features of the proposed classification are as follows: (1) phase of acute neuronal injury (11 cases studied), age 1-2 days, characterized by the presence of neuronal changes, and spongiosis of the neuropil and absence of neuronal ferrugination, chronic inflammation, macrophages, neo-vascularization and cavitation; (2) phase of organization subdivided into: (a) phase of acute inflammation (31 cases), age 3-37 days, characterized by coagulative necrosis, and frequent acute inflammation, and (b) phase of chronic inflammation (57 cases), age 10 days-53 years, characterized by the presence or absence of coagulative necrosis, neuronal injury, red neurons, macrophages, mononuclear inflammatory cells, perivascular cuffing, cavitation, gliosis, spheroids; absence of neutrophils; and (3) phase of resorption (38 cases), age 26 days-23 years, characterized by absence of an inflammatory response. Neuronophagia is not a feature of cerebral infarcts.

Entities:  

Mesh:

Year:  2004        PMID: 15517310     DOI: 10.1007/s00401-004-0918-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  63 in total

Review 1.  Potential importance of B cells in aging and aging-associated neurodegenerative diseases.

Authors:  Arya Biragyn; Maria Aliseychik; Evgeny Rogaev
Journal:  Semin Immunopathol       Date:  2017-01-12       Impact factor: 9.623

2.  Post-Stroke Blood-Brain Barrier Disruption and Poor Functional Outcome in Patients Receiving Thrombolytic Therapy.

Authors:  Zurab Nadareishvili; Alexis N Simpkins; Emi Hitomi; Dennys Reyes; Richard Leigh
Journal:  Cerebrovasc Dis       Date:  2019-04-10       Impact factor: 2.762

3.  Histopathology of diffusion-weighted imaging-positive lesions in cerebral amyloid angiopathy.

Authors:  Annemieke Ter Telgte; Ashley A Scherlek; Yael D Reijmer; Andre J van der Kouwe; Thijs van Harten; Marco Duering; Brian J Bacskai; Frank-Erik de Leeuw; Matthew P Frosch; Steven M Greenberg; Susanne J van Veluw
Journal:  Acta Neuropathol       Date:  2020-02-27       Impact factor: 17.088

4.  Microglial activation during acute cerebral infarction in the presence of diabetes mellitus.

Authors:  Gang Li; Xiaoyun Xu; Desheng Wang; Junchen Wang; Yue Wang; Jinming Yu
Journal:  Neurol Sci       Date:  2011-05-24       Impact factor: 3.307

5.  Partial MHC Constructs Treat Thromboembolic Ischemic Stroke Characterized by Early Immune Expansion.

Authors:  Abby L Dotson; Yingxin Chen; Wenbin Zhu; Nicole Libal; Nabil J Alkayed; Halina Offner
Journal:  Transl Stroke Res       Date:  2015-12-01       Impact factor: 6.829

Review 6.  Does B lymphocyte-mediated autoimmunity contribute to post-stroke dementia?

Authors:  Kristian P Doyle; Marion S Buckwalter
Journal:  Brain Behav Immun       Date:  2016-08-13       Impact factor: 7.217

Review 7.  Stem Cell-Based Immunomodulation After Stroke: Effects on Brain Repair Processes.

Authors:  Marieke C S Boshuizen; Gary K Steinberg
Journal:  Stroke       Date:  2018-05-03       Impact factor: 7.914

8.  Impact of an immune modulator fingolimod on acute ischemic stroke.

Authors:  Ying Fu; Ningnannan Zhang; Li Ren; Yaping Yan; Na Sun; Yu-Jing Li; Wei Han; Rong Xue; Qiang Liu; Junwei Hao; Chunshui Yu; Fu-Dong Shi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

9.  Chilled to the marrow: neonatal brain injury, hypothermia, and the immune system*.

Authors:  Sujatha Kannan
Journal:  Pediatr Crit Care Med       Date:  2013-10       Impact factor: 3.624

10.  Histopathological Investigation of Different MCAO Modalities and Impact of Autologous Bone Marrow Mononuclear Cell Administration in an Ovine Stroke Model.

Authors:  Johannes Boltze; Björn Nitzsche; Kathrin D Geiger; Heinz-Adolf Schoon
Journal:  Transl Stroke Res       Date:  2011-08-23       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.